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ABSTRACT 
Introduction: Acute kidney injury (AKI) requiring dialysis complicates 1% of all hospital 
admissions, and up to 30% of survivors will still require dialysis at hospital discharge.  There is a 
paucity of data to describe the post-discharge outcomes or to guide evidence-based dialysis 
management of this vulnerable population. 
Methods: Single-center, retrospective analysis of 100 consecutive patients with AKI who 
survived to hospital discharge and required outpatient dialysis.  Data collection included baseline 
characteristics, hospitalization characteristics, and outpatient dialysis treatment variables.  
Primary outcome was dialysis independence 90 days after discharge. 
Findings: Overall, 43% of patients recovered adequate renal function to discontinue dialysis, 
with the majority recovering within 30 days post discharge.  Worse baseline renal function was 
associated with lower likelihood of renal recovery.  In the first week post-discharge, patients 
with subsequent non-recovery of renal function had greater net fluid removal (5.3 vs 4.1 L, 
p=0.037), higher ultrafiltration rates (6.0 vs. 4.7 ml/kg/hr, p=0.041) and more frequent 
intradialytic hypotension (24.6% vs. 9.3% with 3 or more episodes, p=0.049) compared to 
patients that later recovered. 
Discussion: A significant proportion of AKI survivors will recover renal function following 
discharge.  Outpatient intradialytic factors may influence subsequent renal function recovery. 
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INTRODUCTION 
Acute kidney injury requiring initiation of dialysis (AKI-D) occurs in approximately 1–
2% of hospitalized patients and 5–7% of critically ill patients, and is associated with hospital 
mortality rates approaching 50%.
1-3
  Among survivors, 10-30% of patients will remain dialysis-
dependent at the time of hospital discharge.
3-5
  Recent studies suggest that the incidence of AKI-
D is rising but survival may be improving,
6, 7
 and therefore increasing numbers of AKI patients 
will require outpatient dialysis. 
AKI patients requiring outpatient dialysis are a vulnerable population who remain at 
substantial risk for complications, yet few studies have focused on this group.  However, it is 
clear that a significant proportion of AKI-D patients can recover renal function even after 
discharge, with rates of dialysis-independence ranging from 20-60%.
4
  The reason for the 
variability in recovery rates is uncertain, and may in part be related to differences between study 
populations in non-modifiable factors such as age and comorbidities, most notably pre-existing 
chronic kidney disease (CKD).
8
  However, the role of potentially modifiable factors, including 
dialysis prescription, has not been extensively explored.  Most studies examining predictors of 
renal recovery have focused on either non-modifiable factors or inpatient treatment factors.
1, 9, 10
  
As a result, there is a lack of evidence-basis and no guidelines for how to optimize outpatient 
management of AKI patients in order to best promote renal recovery and dialysis-
independence.
4, 11
 
Recent studies have provided important insight into current care practices for the high-
risk population of patients with AKI requiring dialysis at hospital discharge.
12, 13
  These studies 
have helped characterize recovery patterns and identified patient factors that may be predictive 
of renal recovery.  At our medical center, it is routine practice for patients with AKI requiring 
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dialysis at discharge to return to the hospital-based dialysis center for outpatient dialysis until 
either they experience renal function recovery or are deemed to have end-stage renal disease 
(ESRD).  The objective of this study was to describe both patient and outpatient treatment factors 
associated with renal recovery in this vulnerable population. 
 
MATERIALS and METHODS 
Design and Setting 
We performed a single-center, retrospective study of adult patients admitted to the 
University of Michigan Health System (UMHS) from January 1, 2013 through July 31, 2015, 
who developed AKI requiring dialysis initiation, and in whom dialysis was still required at 
discharge.  Exclusion criteria were patients with pre-existing diagnosis of ESRD, or those who 
had dialysis initiated at an outside hospital prior to transfer.  This study was approved by the 
UMHS institutional review board with a waiver of informed consent. 
UMHS provides tertiary care to a geographic area including Michigan, northern Indiana 
and northern Ohio.  For patients with AKI-D, the decision to prescribe renal replacement therapy 
is at the discretion of the nephrology consult team, and includes either standard intermittent 
hemodialysis (IHD; at least thrice weekly, with target urea reduction ratio of 70% per treatment) 
or continuous renal replacement therapy (CRRT; performed as continuous veno-venous 
hemodiafiltration with prescribed effluent dose of 25-30 ml/kg/hr, using regional citrate 
anticoagulation
14
).  Patients with AKI-D who survive to hospital discharge but who still require 
dialysis are referred back to dialyze in the hospital-based dialysis unit.  Outpatient dialysis 
treatments are performed by the same team of nurses that provide inpatient dialysis care, and 
supervised by one primary nephrologist and a physician assistant.  Patients are evaluated in-
Page 4 of 25Hemodialysis International
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
5 
 
person at least weekly by the primary nephrologist, and weekly labs are collected to assess for 
trends in serum creatinine and electrolytes.  Timed urine collections are obtained as indicated by 
clinical factors such as signs of recovery (e.g. decreasing pre-dialysis creatinine, patient reported 
increasing urine output).   
 
Data Collection 
Baseline patient characteristics, including comorbid conditions, were collected through 
review of the electronic medical record.  Baseline renal function was defined as estimated 
glomerular filtration rate (eGFR) derived from the average of the 3 most recent outpatient 
creatinine values prior to admission, and calculated using the CKD-EPI equation.
15
  Additional 
variables included cause of AKI (acute tubular necrosis [ATN]; hemodynamic, including 
hepatorenal and cardiorenal syndrome; glomerulonephritis; or other), initial dialysis modality, 
and hospital service.  Laboratory parameters and patient weight were recorded at admission, 
dialysis initiation and time of hospital discharge.  Volume overload at dialysis initiation and 
hospital discharge were calculated as a percentage above/below hospital admission weight: 
[(dialysis initiation weight – admit weight)/admit weight] x 100%.
16
  Urine output (UOP) in the 
24 hours prior to discharge was recorded. 
Outpatient treatment parameters were recorded for the first 3 outpatient dialysis sessions.  
These included dialysis treatment time, net fluid removal, ultrafiltration rate, and occurrence of 
intradialytic hypotension (defined as systolic blood pressure <90 mmHg
17
).  Distance traveled 
for outpatient dialysis was also recorded. 
 
Outcomes 
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The primary outcome was dialysis independence at 90 days post-discharge.  We chose 90 
days because this is typically the time beyond which a patient is designated as ESRD if still 
dialysis-dependent, at which time they are referred to an outpatient dialysis center.  Secondary 
outcomes included eGFR at time of recovery among those achieving dialysis-independence. 
 
Statistical Analyses 
T-tests were used to compare continuous variables between patients recovering renal 
function versus those remaining on dialysis, while categorical variables were assessed using chi-
square tests.  Multivariate logistic regression models were developed to predict the primary 
outcome of dialysis-independence at 90 days, using forward selection and including variables 
with p<0.10 significance in univariate analysis.  Statistical analyses were performed using SAS 
9.3 (SAS Institute Inc., Cary, NC). 
 
RESULTS 
Patient Characteristics 
During the study period 100 patients met inclusion criteria.  Baseline characteristics are 
shown in Table 1.  Mean age was 60.9 years, with 56% male; 76% were white, and 18% were 
black.  Comorbidities were common and 36% had diabetes mellitus (DM) while 35% had 
congestive heart failure (CHF).  The mean baseline eGFR was 60.8 ml/min/1.73m
2
.  Most (53%) 
patients had some degree of CKD at baseline: 38 with stage 3 CKD, 13 with stage 4 CKD, and 2 
with stage 5 CKD.  Overall, 68 patients were admitted to a medicine service and 32 patients to a 
surgery service. 
Page 6 of 25Hemodialysis International
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
7 
 
 Inpatient treatment characteristics are listed in Table 2. For AKI etiology, 68% of cases 
were attributed to ATN, 11% to hemodynamic causes, 11% to glomerulonephritis and 10% to 
other causes.  CRRT was the initiating modality in 30 patients and IHD in the remaining 70 
patients.   
 
Renal Function Recovery 
Overall, 43 patients recovered adequate renal function to be independent of dialysis by 90 
days post-discharge; 16 experienced full recovery to baseline renal function while 27 had new or 
worsened CKD.  Among the remaining 57 patients, 45 were declared ESRD and 9 were 
deceased.  The majority (31 of 43, 72%) of recovering patients were dialysis independent by 30 
days post-discharge.  Among patients recovering renal function, the mean duration of RRT was 
38.6 days and mean eGFR at time of dialysis discontinuation was of 38.1 ml/min/1.73m
2
. 
 
Inpatient Predictors of Renal Recovery 
Patient baseline characteristics by renal recovery are shown in Table 1.  Patients who did 
not recover were marginally older than those that did recover.  Compared to black patients, white 
patients were significantly more likely to recover (47.4% vs. 16.7%, p=0.029).  Non-recovering 
patients had a higher Charlson comorbidity score and lower baseline eGFR compared to those 
that recovered.  DM and CHF were marginally associated with lower likelihood of renal 
recovery.  Patients who recovered had significantly higher baseline eGFR than those that did not 
recover (73.6 vs. 51.6 ml/min/1.73m
2
, p<0.001).  Figure 1 shows renal function recovery over 
time, overall and by underlying CKD status. 
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 Inpatient characteristics and their association with renal outcomes are shown in Table 2.   
The cause of AKI was important in predicting renal recovery: more than half (55.9%) of patients 
with ATN recovered renal function compared to only 9.1% of patients with hepatorenal or 
cardiorenal syndrome, and 18.2% of patients with glomerulonephritis (p=0.002).  A higher 
proportion of patients with initial dialysis modality of CRRT experienced renal recovery 
compared to those that started on IHD (70.1% vs. 31.4%, p<0.001).  There were no differences 
between recovery groups in biochemical parameters or degree of fluid overload at time of 
dialysis initiation. 
 
Discharge and Outpatient Predictors of Renal Recovery 
Patient characteristics at the time of discharge are shown in Table 3.  UOP 24 hours prior 
to discharge was significantly different between groups, (684 vs 279 ml, p=0.002).  Albumin was 
marginally higher among patients that subsequently recovered compared to those that did not 
(3.1 vs 2.9 g/dL, p=0.075), but there were no differences in other biochemical parameters.  The 
degree of fluid overload at discharge was similar between the recovery and non-recovery groups, 
and there was also no difference in the change of fluid overload from RRT initiation to discharge 
(a surrogate for net volume of inpatient ultrafiltration). 
Outpatient dialysis treatment characteristics during the first week post-discharge are 
shown in Table 4.  Hemodynamic parameters at beginning and end of dialysis treatment were 
similar between the recovery and non-recovery groups.  Patients with non-recovery of renal 
function had marginally more episodes of intradialytic hypotension, and a significantly greater 
proportion of these patients had 3 or more episodes of intradialytic hypotension during the week 
(24.6% vs. 9.3%, p=0.049). 
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Multivariate Analysis 
Table 5 shows the results of a multivariate logistic regression model to predict recovery 
of renal function at 90 days post-hospital discharge.  Significant negative predictors of renal 
recovery were black compared to white race, and initial RRT modality of IHD compared to 
CRRT.  The development of 3 or more episodes of intradialytic hypotension was also marginally 
significant in predicting non-recovery. 
 
DISCUSSION 
In this cohort study of patients with AKI-D who survived to hospital discharge but 
remained dialysis-dependent, we found that post-discharge renal recovery was common.  
Overall, 43% of patients recovered adequate renal function to discontinue hemodialysis therapy 
by 90 days, including 16% that fully recovered to prior baseline renal function.  A novel aspect 
of this study was the examination of outpatient dialysis practices in this population.  Notably, 
when examining post-discharge dialysis care, greater fluid removal and more frequent 
hypotensive episodes appeared to be associated with decreased likelihood of renal recovery. 
The vast majority of studies of patients with severe AKI have focused on the inpatient 
setting, with relatively little attention paid to the care of patients who survive to hospital 
discharge but still require dialysis as outpatients.  Recent studies have begun to shed some light 
on the epidemiology and outcomes of these patients.  Hickson and colleagues reported the Mayo 
Clinic experience with 281 patients and observed that 21% recovered to dialysis-independence in 
the 6 months post-discharge.
12
  Baseline renal impairment (eGFR <30 ml/min) and CHF were 
associated with decreased likelihood of renal recovery.  Of note, patients in the Mayo study 
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appeared to have greater comorbidity burden compared to our cohort (mean Charlson Index of 7 
compared to 2.75).  Gautam and colleagues recently described 119 patients with AKI treated at a 
University of Virginia facility developed specifically to provide dialysis for AKI outpatients.  
Overall, 42% developed dialysis-independence within 90 days of discharge.
13
  In univariate 
analyses, predictors of non-recovery included CHF, prior AKI within 6 months, and lower 
baseline eGFR.  The most consistent finding from all 3 studies is the association between 
baseline renal impairment and risk for renal non-recovery.  Of note, patients with baseline eGFR 
>60 ml/min made up 48% of the UVA cohort and 43% of our cohort; conversely, in the Mayo 
cohort only 15% of patients had baseline GFR >60 ml/min, which may account for the lower 
recovery rate seen in that study.  CHF was also identified as a negative predictor of recovery in 
all three studies, although this was only a marginally significant finding in our cohort.  In 
adjusted analyses, in contrast to other studies, we no longer found a history of CHF to be a 
significant predictor of renal function non-recovery.  Potential explanations include the relatively 
small sample size or differences in severity of CHF (not captured) between study populations.  
It’s also possible that the association between CHF and renal non-recovery is mediated by 
increased risk for intradialytic hypotension, which we adjusted for in our models; however, in 
subgroup analysis there was no significant difference in hypotensive episodes between CHF 
versus non-CHF patients (1.7 vs 1.5 episodes, p=0.781).  Larger studies are needed to further 
elucidate the relationship between CHF and renal function recovery after an episode of AKI. 
 The predictive factors identified above are non-modifiable.  While this information may 
be helpful in counseling patients and planning care, it does not provide insight into practices that 
may improve renal recovery rates.  Our study is novel in that it is the first to evaluate outpatient 
dialysis treatment factors and their effect on renal outcomes.  Compared to patients with renal 
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recovery, we found that patients with non-recovery of renal function had higher net fluid 
removal and ultrafiltration rates, despite these groups having similar degrees of fluid overload at 
the time of discharge.  Similarly, patients with non-recovery of renal function suffered from 
more frequent episodes of intradialytic hypotension.  It is possible that this association reflects 
underlying patient severity of illness as opposed to being a causative factor in non-recovery of 
renal function.  However, there is ample evidence of the harms of intradialytic hypotension on 
other organ systems,
18-20
 lending biologic plausibility to a pathologic role in impairing renal 
recovery.  Our results provide preliminary support to recent recommendations calling for a 
conservative approach to fluid removal in AKI patients with the goal of minimizing risk of 
intradialytic hypotension.
21
 
 Our study also has timely implications due to upcoming Medicare policy changes.  The 
“Trade Bill” (passed on June 29, 2015 and effective January 1, 2017) will allow Medicare to 
reimburse for dialysis care provided to AKI outpatients at ESRD facilities, a reversal from the 
previous position.
22
  As such, it is likely that more AKI patients will be entering a realm which is 
most accustomed to chronic dialysis patients where the prospect of recovery of renal function is 
remote, and clinician focus is on achieving effective dialysis and establishing dry weight.  For 
AKI patients, clinicians will need to be vigilant in monitoring for renal function recovery and in 
avoiding complications such as intradialytic hypotension. This further underscores the need to 
complete more definitive studies of treatment related parameters that may affect renal recovery. 
Our study has important limitations. As an observational study, we cannot establish a 
causative role of fluid removal or intradialytic hypotension in contributing to renal function non-
recovery.  Additionally, this study is single-center, which may confound generalizability.  
However, we were able to examine treatment parameters in a granular fashion, which is not 
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currently otherwise feasible with existing regional or national data sources.  We limited our 
analysis of outpatient dialysis treatment to the first week post-discharge, and it is possible that 
treatment factors beyond the first week played a role in subsequent renal function recovery or 
non-recovery.  We chose to limit to this timeframe for feasibility reasons (decreasing patient 
numbers beyond 1 week due to recovery), and also because we believe that the first week is the 
most vulnerable period for complications and thus the most important to characterize.   
In summary, among patients with AKI surviving to hospital discharge but remaining 
dialysis-dependent, we observed a high rate of subsequent renal function recovery.  We have 
identified both non-modifiable and potentially modifiable risk factors for non-recovery.  At the 
very least, this information can inform clinicians when counseling these patients and their 
families.  Our data also suggest an association between outpatient dialysis prescription factors 
and subsequent renal recovery.  Clinical trials are needed to determine whether strategies to 
minimize intradialytic hypotension may be beneficial in promoting renal function recovery. 
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Figure 1: Outpatient renal function recovery during the initial 90 days after hospital discharge, 
overall and by underlying CKD status. 
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Table 1: Patient characteristics at hospital admission, overall and by 90 day outcome 
  90 Day Outcome  
Variable* Overall 
(n=100) 
Off Dialysis 
(n=43) 
ESRD or 
Death 
(n=57) 
p-value 
Age in years 60.9 (14.6) 57.9 (15.9) 63.2 (13.2) 0.071 
Race: White 
  Black 
  Other 
76 
18 
6 
36 (47.4%) 
3 (16.7%) 
4 (66.7%) 
40 (52.6%) 
15 (83.3%) 
2 (33.3%) 
0.029 
Gender: Male 
  Female 
56 
44 
24 (42.9%) 
19 (43.2%) 
32 (57.1%) 
25 (56.8%) 
0.974 
Charlson Comorbidity 
Index 
2.75 (1.81) 2.32 (1.74) 3.07 (1.80) 0.041 
Comorbidities: 
  Diabetest Mellitus 
  Hypertension 
  Congestive Heart Failure 
  Active Cancer 
  Coronary Artery Disease 
  Peripheral Vascular 
Disease 
  Cirrhosis 
 
36 
61 
35 
11 
20 
18 
14 
 
11 (30.6%) 
25 (41.0%) 
11 (31.4%) 
4 (36.4%) 
6 (30%) 
8 (44.4%) 
6 (42.9%) 
 
25 (69.4%) 
36 (59.0%) 
24 (68.6%) 
7 (63.6%) 
14 (70%) 
10 (55.6%) 
8 (57.1%) 
 
0.059 
0.611 
0.086 
0.638 
0.189 
0.891 
0.991 
Primary Service:    0.007 
Page 16 of 25Hemodialysis International
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
17 
 
  Medicine 
  Surgery 
68 
32 
23 (36.8%) 
20 (62.5%) 
45 (66.2%) 
12 (37.5%) 
Baseline eGFR 
(ml/min/1.73m
2
) 
60.8 (30.5) 73.6 (28.8) 51.6 (28.6) <0.001 
Admission Labs: 
  Serum creatinine, mg/dL 
  BUN, mg/dL 
  Albumin, g/dL 
  Hemoglobin, g/dL 
 
3.57 (2.96) 
58.1 (38.3) 
3.15 (0.64) 
10.3 (2.3) 
 
3.20 (3.33) 
49.7 (41.2) 
3.2 (0.6) 
10.8 (2.6) 
 
3.85 (2.64) 
64.3 (35.0) 
3.1 (0.7) 
9.7 (2.0) 
 
0.285 
0.060 
0.310 
0.049 
*Values for continuous variables are presented as means (SD).  Values for categorical variables 
are presented as counts (% of total). 
ESRD: end-stage renal disease; eGFR: estimated glomerular filtration rate; BUN: blood urea 
nitrogen 
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Table 2: Inpatient treatment characteristics, overall and by 90 day outcome 
  90 Day Outcome 
Variable* Overall 
(n=100) 
Off Dialysis 
(n=43) 
ESRD or 
Death 
(n=57) 
p-value 
Cause of AKI 
  ATN 
  Hemodynamic 
(hepatorenal syndrome, 
cardiorenal syndrome) 
  Glomerulonephritis 
  Other 
 
68 
11 
 
 
11 
10 
 
38 (55.9%) 
1 (9.1%) 
 
 
2 (18.2%) 
2 (20.0%) 
 
30 (44.1%) 
10 (90.9%) 
 
 
9 (81.8%) 
8 (80.0%) 
0.002 
 
Initial RRT Modality:  
  CRRT 
  IHD 
 
30 
70 
 
21 (70%) 
22 (31.4%) 
 
9 (30%) 
48 (68.6%) 
<0.001 
Mechanical Ventilation 42 25 (59.5%) 17 (40.5%) 0.005 
Vasopressor Use 27 20 (74.1%) 7 (25.9%) <0.001 
RRT Initiation Labs: 
  Serum creatinine, 
mg/dL 
  BUN, mg/dL 
  Albumin, g/dL 
  Hemoglobin, g/dL 
 
5.72 (2.64) 
 
84.9 (38.0) 
2.94 (0.55) 
9.1 (1.6) 
 
5.63 (2.96) 
 
78.2 (42.1) 
3.0 (0.5) 
9.3 (1.9) 
 
5.79 (2.39) 
 
89.9 (34.1) 
2.9 (0.6) 
8.9 (1.4) 
 
0.770 
 
0.128 
0.555 
0.318 
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% Fluid Overload at 
RRT Initiation 
>10% Fluid Overload at 
RRT Initiation 
 
6.1% (9.4) 
 
24  
 
5.8% (9.5) 
 
12 (50%) 
 
6.3% (9.5) 
 
12 (50%) 
 
0.818 
 
0.544 
*Values for continuous variables are presented as means (SD).  Values for categorical variables 
are presented as counts (% of total). 
ESRD: end-stage renal disease; AKI: acute kidney injury; ATN: acute tubular necrosis; RRT: 
renal replacement therapy; CRRT: continuous renal replacement therapy; IHD: intermittent 
hemodialysis therapy; BUN: blood urea nitrogen 
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Table 3: Patient characteristics at time of discharge/first outpatient dialysis, overall and by 90 
day outcome 
  90 Day Outcome 
Variable* Overall 
(n=100) 
Off Dialysis 
(n=43) 
ESRD or 
Death 
(n=57) 
p-value 
Inpatient RRT Days 14.9 (11.8) 16.3 (13.7) 13.8 (10.1) 0.314 
Urine Output (last 24 
hours of hospitalization) 
453 (605) 684 (733) 279 (416) 0.002 
Discharge Labs: 
  Serum Creatinine, 
mg/dL 
  BUN, mg/dL 
  Albumin, g/dL 
  Hemoglobin, g/dL 
 
4.79 (2.19) 
 
43.5 (20.6) 
3.0 (0.6) 
8.7 (1.2) 
 
4.99 (2.45) 
 
43.6 (20.4) 
3.1 (0.4) 
8.8 (1.2) 
 
4.63 (1.97) 
 
43.4 (21.0) 
2.9 (0.6) 
8.6 (1.3) 
 
0.423 
 
0.956 
0.075 
0.535 
% Fluid Overload at 
Discharge 
-2.1 (11.8) -3.9 (12.1) -0.8 (11.5) 0.224 
Change in Fluid 
Overload from RRT 
Initiation 
-8.3 (11.2) -9.9 (12.7) -7.1 (9.9) 0.238 
*Values for continuous variables are presented as means (SD).  Values for categorical variables 
are presented as counts (% of total). 
ESRD: end-stage renal disease; RRT: renal replacement therapy; BUN: blood urea nitrogen 
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Table 4: Outpatient dialysis treatment characteristics, overall and by 90 day outcome 
  90 Day Outcome 
Variable* Overall 
(n=100) 
Off Dialysis 
(n=43) 
ESRD or 
Death 
(n=57) 
p-value 
Duration of Dialysis 
Session, hours 
3.3 (0.6) 3.2 (0.7) 3.4 (0.6) 0.305 
Pre-Dialysis Weight 
(first session), kg 
88.5 (23.0) 91.3 (25.7) 86.4 (20.8) 0.306 
Pre-Dialysis MAP, 
mmHg 
94.0 (17.5) 96.8 (17.6) 91.8 (17.3) 0.159 
Post-Dialysis MAP, 
mmHg 
91.4 (14.5) 92.5 (14.9) 90.6 (14.3) 0.507 
Change in MAP, mmHg 2.6 (11.1) 4.3 (12.8) 1.3 (9.4) 0.195 
Hypotension 
  # Episodes 
  Any Episode 
  >3 Episodes 
 
1.6 (3.7) 
25  
18  
 
0.9 (2.9) 
8 (32%) 
4 (22.2%) 
 
2.1 (4.2) 
17 (68%) 
14 (77.8%) 
 
0.104 
0.200 
0.049 
Ultrafiltration per 
session, L 
1.60 (0.95) 1.37 (0.97) 1.77 (0.90) 0.037 
Ultrafiltration rate, 
ml/kg/hr 
5.4 (3.2) 4.68 (3.16) 6.02 (3.15) 0.041 
One-Way Travel 17.1 (21.2) 19.3 (22.5) 15.4 (20.2) 0.370 
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Distance, miles 
*Values for continuous variables are presented as means (SD).  Values for categorical variables 
are presented as counts (% of total). 
ESRD: end-stage renal disease; MAP: mean arterial pressure 
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Table 5: Logistic regression model predicting renal function recovery at 90 days post-hospital 
discharge 
Variable OR 95% CI p-value 
Black Race (vs. White) 0.14 0.02-0.84 0.031 
Baseline eGFR (per mL/min) 1.22 1.02-1.47 0.034 
IHD vs CRRT 0.19 0.06-0.61 0.006 
Urine Output at Discharge (per 100mL) 1.14 1.03-1.26 0.011 
> 3 Episodes of Hypotension 0.26 0.06-1.22 0.088 
eGFR: estimated glomerular filtration rate; IHD: intermittent hemodialysis; CRRT: continuous 
renal replacement therapy 
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Figure 1: Outpatient renal function recovery during the initial 90 days after hospital discharge, overall and 
by underlying CKD status.  
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